Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
02 Janeiro 2025 - 6:30PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global
leader in life science research and clinical diagnostics products,
today announced that the company's Chief Executive Officer Norman
Schwartz, Chief Operating Officer Jon DiVincenzo, and Chief
Financial Officer Roop K. Lakkaraju will host one-on-one meetings
with analysts and investors during J.P. Morgan's 43rd Annual
Healthcare Conference in San Francisco, CA, January 13-16,
2025.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in
developing, manufacturing, and marketing a broad range of products
for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of
research, development, manufacturing, and sales operations with
approximately 7,700 employees, and $2.7 billion in revenues in
2023. Our customers include universities, research institutions,
hospitals, and biopharmaceutical companies, as well as clinical,
food safety and environmental quality laboratories. Together, we
develop innovative, high-quality products that advance science and
save lives. To learn more, visit bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250102060278/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 cc@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Bio Rad Laboratories (NYSE:BIO)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
